Vinylbital
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Excretion | Renal |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.017.633 |
| Chemical and physical data | |
| Formula | C11H16N2O3 |
| Molar mass | 224.260 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Vinylbital, also known as butylvinal, is a sedative hypnotic drug which is a barbiturate derivative.[2] It was developed by Aktiebolaget Pharmacia in the 1950s.[3][failed verification]
References
[edit]- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- ^ Breimer DD, de Boer AG (1976). "Pharmacokinetics and relative bioavailability of vinylbital in man after oral and rectal administration". Arzneimittel-Forschung. 26 (3): 448–54. PMID 989344.
- ^ US 2868790, Brandstrom AE, "Manufacture of Barbituric Acid Compounds", issued 13 January 1959, assigned to Pharmacia
 | This sedative-related article is a stub. You can help Wikipedia by expanding it. |